United Therapeutics (NASDAQ:UTHR) Given “Equal Weight” Rating at Wells Fargo & Company
United Therapeutics (NASDAQ:UTHR – Get Free Report)‘s stock had its “equal weight” rating reaffirmed by equities researchers at Wells Fargo & Company in a report issued on Friday, MarketBeat.com reports. They currently have a $314.00 price target on the biotechnology company’s stock, down from their prior price target of $395.00. Wells Fargo & Company‘s target […]
United Therapeutics (NASDAQ:UTHR – Get Free Report)‘s stock had its “equal weight” rating reaffirmed by equities researchers at Wells Fargo & Company in a report issued on Friday, MarketBeat.com reports. They currently have a $314.00 price target on the biotechnology company’s stock, down from their prior price target of $395.00. Wells Fargo & Company‘s target […]
